Market Segmentation:
- By Product Type
- Hemostats
- Sealants
- Adhesives
- Soft-Tissue Repair
- Bone Graft Substitutes
- Wound Care
- Others (Tissue Engineering Products, Biomaterials)
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Academic and Research Institutes
- Others (Home Healthcare, Long-Term Care Facilities)
- By Application
- Cardiovascular Surgery
- Orthopedic Surgery
- Neurological Surgery
- General Surgery
- Wound Care
- Others (Urological Surgery, Ophthalmology, Dental)
- By Material
- Collagen-based
- Protein-based
- Polysaccharide-based
- Synthetic-based
- Others (Ceramic-based, Polymer-based)
- By Technology
- Tissue Engineering
- Regenerative Medicine
- Biomaterials
- Biological Adhesives
- Biological Sealants
- Others (Biological Hemostats, Biological Wound Care)
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East, and Africa
Frequently Asked Questions
The current market size of the Biosurgery industry is US$ 11,542 million in 2023.
Key factors driving the growth of the Biosurgery market include the increasing prevalence of chronic diseases, the growing geriatric population, advancements in medical technology, the rising demand for minimally invasive surgical procedures, and the integration of AI and ML in biosurgical products.
The key factors hampering the growth of the Biosurgery Market include the high cost of biosurgical products, the stringent regulatory approval process, limited reimbursement coverage for some biosurgical procedures, and concerns about the availability and reliability of biological materials.
The leading component segment in the Biosurgery Market is the Hemostats segment, which plays a crucial role in controlling bleeding during surgical procedures.
The major players operating in the Biosurgery Market include Baxter International Inc., Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation, and Anika Therapeutics, Inc., among others.
The Biosurgery Market is expected to grow at a CAGR of 6.1% from 2024 to 2031, with a projected market size of US$ 18,535.5 million by 2031.
The key drivers of the Biosurgery Market include the increasing prevalence of chronic diseases, the growing geriatric population, advancements in medical technology, the rising demand for minimally invasive surgical procedures, and the integration of AI and ML in biosurgical products.